Delivery Order SPE2DB24D2101-SPE2DB24FKGHJ

Award Date 9/5/24
Potential Completion Date 9/6/24
Potential Value $9.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $10,160.54 firm fixed-price contract is for the supply of ORENCIA 250 MG VIALS, a pharmaceutical product. The delivery order has a completion date of June 11, 2025. Amerisourcebergen Drug Corp is the prime contractor, and this award is not set-aside. The company holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
The U.S. Defense Logistics Agency (DLA) awarded a $6,998.08 firm fixed-price delivery order contract to AmerisourceBergen Drug Corporation's Corporate Office division for the supply of Orencia ClickJect 125 mg/ml pharmaceutical products. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for providing a comprehensive range of medical commodities to support military treatment programs...
This is a $13,493.18 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) to provide ORENCIA 250 MG VIALS. The contract has an ultimate completion date of July 9, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,313.48 firm-fixed-price contract is for the supply of Orencia 125 mg/mL syringes, with a completion date of November 22, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $9,926.49 firm fixed-price contract is for the supply of ORENCIA 125 MG/ML SYRINGEML, a specialty pharmaceutical product. The contract has an ultimate completion date of April 10, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,983.68 firm fixed price delivery order is for the supply of ORENCIA 250 MG VIALS, a pharmaceutical product. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract, valued at $10,173.60, is for the supply of Orencia 250 mg vials, a specialty pharmaceutical product. The contract has a firm-fixed price pricing type and an ultimate completion date of September 12, 2024. Amerisourcebergen Drug Corporation is a large pharmaceutical distributor that holds several Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $32,251.07 Firm Fixed Price Delivery Order is for the supply of ORENCIA 125 MG/ML SYRINGEML, a specialty medication. The contract has an ultimate completion date of November 18, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the supply of 250 mg vials of the pharmaceutical drug Orencia. The contract is valued at $30,914.07 and has a period of performance ending on August 26, 2024. The contract is a firm-fixed-price delivery order with no set-aside designation. AmerisourceBergen, as a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of essential medical...
This is a $12,002.20 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ORENCIA 250 MG VIALS, a pharmaceutical product, with a period of performance through June 23, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
  • SPE2DB24D2101
    Indefinite Delivery Contract
  • SPE2DB24D2101-SPE2DB24FKGHJ
    Delivery Order

This is a $9,234.61 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of Orencia 250 mg vials, a specialty pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to support military healthcare programs. The contract does not have a set-aside designation and is expected to be completed by September 6, 2024. As a major pharmaceutical distributor, Amerisourcebergen leverages its extensive supply chain to provide critical medications, supplies, and equipment to various federal agencies and healthcare providers, including the military.

Generated 12/5/24, 9:03 AM